Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.37 |
| ▸ | SHBG | P04278 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.31 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL39548 | 0.80 | CYP1A2 (0.39) | CYP1A2SHBG | |
| SCHEMBL5083323 | 0.79 | CYP1A2 (0.37) | CYP1A2SHBGMEN1ALDH1A1LMNA | |
| SCHEMBL1030996 | 0.79 | CYP1A2 (0.37) | CYP1A2SHBGMEN1ALDH1A1LMNA | |
| SCHEMBL3000331 | 0.78 | CYP1A2 (0.40) | CYP1A2SHBG | |
| SCHEMBL17976970 | 0.77 | CYP1A2 (0.36) | CYP1A2SHBGMEN1ALDH1A1LMNA | |
| SCHEMBL4189609 | 0.76 | SIGMAR1 (0.36) | LMNASMN1; SMN2SIGMAR1 | |
| SCHEMBL1900863 | 0.76 | SIGMAR1 (0.36) | LMNASMN1; SMN2SIGMAR1 | |
| SCHEMBL13640032 | 0.76 | CYP1A2 (0.33) | CYP1A2 | |
| SCHEMBL4977291 | 0.75 | CYP1A2 (0.34) | CYP1A2SHBGMEN1ALDH1A1LMNA | |
| SCHEMBL17337998 | 0.74 | SIGMAR1 (0.34) | LMNASMN1; SMN2SIGMAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 58 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115286657-A | Continuous production method of hydroxymethyl phosphonate | 湖北理工学院 | 2022-11-04 | — | — | CN | claimed |
| US-9187504-B2 | Method of making hydroxymethylphosphonate | ICL-IP AMERICA INC. (US) | 2015-11-17 | — | — | US | claimed |
| EP-2376507-B1 | METHOD OF MAKING HYDROXYMETHYLPHOSPHONATES | ICL IP AMERICA INC (US) | 2013-05-15 | — | — | EP | claimed |
| US-8198341-B2 | Method of making hydroxymethylphosphonate, polyurethane foam-forming compositions, polyurethane foam and articles made therefrom | ICL-IP AMERICA INC. (US) | 2012-06-12 | — | — | US | claimed |
| US-20110257287-A1 | Method of Making Hydroxymethylphosphonate, Polyurethane Foam-Forming Compositions, Polyurethane Foam and Articles Made Therefrom | STOWELL JEFFREY K | 2011-10-20 | — | — | US | claimed |
| EP-2376507-A1 | METHOD OF MAKING HYDROXYMETHYLPHOSPHONATE, POLYURETHANE FOAM-FORMING COMPOSITIONS POLYURETHANE FOAM AND ARTICLES MADE THEREFORM | ICL-IP America Inc. (US) | 2011-10-19 | — | — | EP | claimed |
| WO-2010080425-A1 | METHOD OF MAKING HYDROXYMETHYLPHOSPHONATE, POLYURETHANE FOAM-FORMING COMPOSITIONS POLYURETHANE FOAM AND ARTICLES MADE THEREFORM | SUPRESTA LLC. (US) | 2010-07-15 | — | — | WO | claimed |
| US-20100160468-A1 | Method of making hydroxymethylphosphonate, polyurethane foam-forming compositions, polyurethane foam and articles made therefrom | ICL-IP AMERICA INC. | 2010-06-24 | — | — | US | claimed |
| EP-0676429-B1 | Composition for urethane-based plastic lens | MITSUI CHEMICALS INC (JP) | 2000-12-27 | — | — | EP | claimed |
| CN-114269735-B | Dihydro-or tetrahydroquinazoline compound, intermediate thereof, preparation method and application | 南京创济生物医药有限公司 | 2024-02-23 | — | — | CN | disclosed |
| CN-115703855-A | Catalyst system for C4 liquefied petroleum gas cationic polymerization and polybutene production method | 南京中科康润新材料科技有限公司 | 2023-02-17 | — | — | CN | disclosed |
| WO-2023016561-A1 | CATALYST SYSTEM FOR CATIONIC POLYMERIZATION OF C4 LIQUEFIED PETROLEUM GAS AND POLYBUTYLENE PRODUCTION METHOD | 南京中科康润新材料科技有限公司 | 2023-02-16 | — | — | WO | disclosed |
| CN-115286657-A | Continuous production method of hydroxymethyl phosphonate | 湖北理工学院 | 2022-11-04 | — | — | CN | disclosed |
| CN-107383093-B | Hydroxymethylphosphonate, compositions, polyurethane foams, and articles | ICL-IP美国有限公司 | 2021-07-16 | — | — | CN | disclosed |
| US-20070241313-A1 | polymerizing a polymerization raw material in contact with polarizing film; raw material composition contains as one main component an isocyanated or isothiocyanated compound which reacts with the hydroxyl of polyvinyl alcohol resin of polarizing film to form a urethane bond or thiourethane bond | SUNLUX CO., LTD. (JP) | 2007-10-18 | — | — | US | disclosed |
| EP-1739462-A1 | POLARIZING PLASTIC OPTICAL DEVICE AND PROCESS FOR PRODUCING THE SAME | Sunlux Co., Ltd. (JP) | 2007-01-03 | — | — | EP | disclosed |
| EP-0676429-B1 | Composition for urethane-based plastic lens | MITSUI CHEMICALS INC (JP) | 2000-12-27 | — | — | EP | disclosed |
| US-5693738-A | REACTING AN ISOCYANATE AND/OR AN ISOTHIOCYANATE COMPOUND WITH A HYDROXYL AND/OR MERCAPTO-CONTAINING COMPOUND IN THE PRESENCE OF A COMPLEX OF A TERTIARY AMINE AND A LEWIS ACID | MITSUI TOATSU CHEMICALS, INC. (JP) | 1997-12-02 | — | — | US | disclosed |
| EP-0676429-A2 | Composition for urethane-base plastic lens | MITSUI TOATSU CHEMICALS, INCORPORATED (JP) | 1995-10-11 | — | — | EP | disclosed |
| US-4292196-A | Catalyst recovery | UOP INC. (US) | 1981-09-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110257287-A1 | Method of Making Hydroxymethylphosphonate, Polyurethane Foam-Forming Compositions, Polyurethane Foam and Articles Made Therefrom | PFAS, PGM2, NEFM | CYP1A2 3928/4885SHBG 2239/4885MEN1 3375/4885 |
| US-20100160468-A1 | Method of making hydroxymethylphosphonate, polyurethane foam-forming compositions, polyurethane foam and articles made therefrom | PFAS, PGM2, NEFM | CYP1A2 3928/4885SHBG 2239/4885MEN1 3375/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.